Cai International Share Price (NYSE: CAI)

$17.68

▲

-0.94

(-5.05%)

Last updated on March 13, 2026 at 1:29 am IST

$₹

Check the interactive Cai International Stock chart to analyse performance

Cai International stock performance

as on March 13, 2026 at 1:29 am IST

Today's Low:$17.53
Today's High:$18.26
$17.68
0.85%
Downside
Day's Volatility :4.0%
Upside
3.18%
52 Weeks Low:$17.15
52 Weeks High:$42.50
$17.68
3.0%
Downside
52 Weeks Volatility :59.65%
Upside
58.4%

Cai International Stock Returns

Period	Cai International Inc	Index (Russel 2000)
3 Months	-33.89%	0.0%
6 Months	-45.33%	0.0%
1 Year	-36.82%	0.0%
3 Years	-33.5%	1.4%

Cai International Inc Key Stats

Check Cai International key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$18.62
Open	$18.3
Today's High	$18.26
Today's Low	$17.53
Market Capitalization	$5.3B
Today's Volume	$2.2M
52 Week High	$42.5
52 Week Low	$17.15
Revenue TTM	$812.0M
EBITDA	$67.7M
Earnings Per Share (EPS)	$-3.22
Profit Margin	-8.39%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-45.37%

Stock Returns calculator for Cai International Stock including INR - Dollar returns

The Cai International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cai International investment value today

Current value as on today

₹1,00,000

Returns

₹0

(0%)

Returns from Cai International Stock

₹0 (0%)

Dollar Returns*

₹0 (0%)

Indian investors sentiment towards Cai International Stock

38%

Period: Feb 10, 2026 to Mar 12, 2026. Change in 30 Days versus previous period

Search interest for Cai International Stock from India on INDmoney has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Cai International Stock

Rating

Trend

Cai International Share Price Target

What analysts predicted

Upside of 90.05%

Target:

$33.60

Current:

$17.68

Cai International share price target is $33.60, a slight Upside of 90.05% compared to current price of $17.68 as per analysts' prediction.

Cai International Stock Insights

Price Movement
In the last 3 months, CAI stock has moved down by -30.4%

Cai International Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY22

FY23

FY24

FY25

	FY19	Y/Y Change
Revenue	$416.5M	↓ 3.6%
Net Income	$31.0M	↓ 60.54%
Net Profit Margin	7.44%	↓ 10.75%

	FY20	Y/Y Change
Revenue	$294.0M	↓ 29.42%
Net Income	$27.7M	↓ 10.57%
Net Profit Margin	9.43%	↑ 1.99%

	FY22	Y/Y Change
Revenue	$258.5M	↓ 12.08%
Net Income	$-320.8M	↓ 1256.84%
Net Profit Margin	-124.12%	↓ 133.55%

	FY23	Y/Y Change
Revenue	$306.1M	↑ 18.43%
Net Income	$-341.4M	↑ 6.42%
Net Profit Margin	-111.53%	↑ 12.59%

	FY24	Y/Y Change
Revenue	$412.3M	↑ 34.67%
Net Income	$-281.9M	↓ 17.43%
Net Profit Margin	-68.38%	↑ 43.15%

	FY25	Y/Y Change
Revenue	$812.0M	↑ 96.97%
Net Income	$-538.0M	↑ 90.84%
Net Profit Margin	-66.25%	↑ 2.13%

Q1 FY24

Q2 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

	Q1 FY24	Q/Q Change
Revenue	$80.7M	↓ 19.98%
Net Income	$-111.0M	↓ 317.04%
Net Profit Margin	-137.62%	↓ 188.36%

	Q2 FY24	Q/Q Change
Revenue	$100.0M	↑ 24.01%
Net Income	$-66.2M	↓ 40.39%
Net Profit Margin	-66.15%	↑ 71.47%

	Q1 FY25	Q/Q Change
Revenue	$120.9M	↑ 20.86%
Net Income	$-102.6M	↑ 54.99%
Net Profit Margin	-84.84%	↓ 18.69%

	Q2 FY25	Q/Q Change
Revenue	$181.4M	↑ 50.02%
Net Income	$-71.8M	↓ 30.02%
Net Profit Margin	-39.58%	↑ 45.26%

	Q3 FY25	Q/Q Change
Revenue	$216.8M	↑ 19.53%
Net Income	$24.3M	↓ 133.88%
Net Profit Margin	11.22%	↑ 50.8%

	Q4 FY25	Q/Q Change
Revenue	$292.9M	↑ 35.07%
Net Income	$-387.9M	↓ 1694.7%
Net Profit Margin	-132.44%	↓ 143.66%

FY19

FY20

FY22

FY23

FY24

FY25

	FY19	Y/Y Change
Profit	$200.5M	↓ 6.14%

	FY20	Y/Y Change
Profit	$184.2M	↓ 8.16%

	FY22	Y/Y Change
Profit	$80.0M	↓ 56.55%

	FY23	Y/Y Change
Profit	$89.3M	↑ 11.61%

	FY24	Y/Y Change
Profit	$178.8M	↑ 100.18%

	FY25	Y/Y Change
Profit	$539.2M	↑ 201.58%

Q1 FY24

Q2 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

	Q1 FY24	Q/Q Change
Profit	$26.1M	↓ 51.72%

	Q2 FY24	Q/Q Change
Profit	$37.6M	↑ 43.81%

	Q1 FY25	Q/Q Change
Profit	$57.1M	↑ 51.95%

	Q2 FY25	Q/Q Change
Profit	$113.7M	↑ 99.23%

	Q3 FY25	Q/Q Change
Profit	$147.5M	↑ 29.75%

	Q4 FY25	Q/Q Change
Profit	$220.9M	↑ 49.77%

FY19

FY20

FY22

FY23

FY24

FY25

	FY19	Y/Y Change
Operating Cash Flow	$254.0M	↑ 41.29%
Investing Cash Flow	$-271.9M	↓ 59.02%
Financing Cash Flow	$-108.5M	↓ 121.17%

	FY20	Y/Y Change
Operating Cash Flow	$277.0M	↑ 9.06%
Investing Cash Flow	$-34.0M	↓ 87.51%
Financing Cash Flow	$-249.9M	↑ 130.35%

	FY22	Y/Y Change
Operating Cash Flow	$-285.7M	↓ 203.14%
Investing Cash Flow	$-283.0M	↑ 733.1%
Financing Cash Flow	$10.4M	↓ 104.18%

	FY23	Y/Y Change
Operating Cash Flow	$-276.1M	↓ 3.36%
Investing Cash Flow	$214.8M	↓ 175.9%
Financing Cash Flow	$10.1M	↓ 3.0%

	FY24	Y/Y Change
Operating Cash Flow	$-245.2M	↓ 11.19%
Investing Cash Flow	$52.9M	↓ 75.35%
Financing Cash Flow	$200.3M	↑ 1876.83%

	FY25	Y/Y Change
Operating Cash Flow	$83.2M	↓ 133.91%
Investing Cash Flow	$-16.3M	↓ 130.72%
Financing Cash Flow	$665.0M	↑ 232.01%

Q1 FY24

Q2 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-73.9M	↓ 175.73%
Investing Cash Flow	$59.6M	↓ 111.57%
Financing Cash Flow	$200.1M	↓ 53.33%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-62.9M	↓ 14.88%
Investing Cash Flow	$-2.6M	↓ 104.34%
Financing Cash Flow	$-129.0K	↓ 100.06%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-31.3M	↓ 50.2%
Investing Cash Flow	$-2.7M	↑ 3.9%
Financing Cash Flow	$1.3M	↓ 1096.12%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$7.3M	↓ 123.26%
Investing Cash Flow	$-1.4M	↓ 48.46%
Financing Cash Flow	$681.4M	↑ 52927.39%

	Q3 FY25	Q/Q Change
Operating Cash Flow	$62.4M	↑ 756.55%
Investing Cash Flow	$-7.1M	↑ 411.9%
Financing Cash Flow	$-21.1M	↓ 103.1%

	Q4 FY25	Q/Q Change
Operating Cash Flow	$44.8M	↓ 28.27%
Investing Cash Flow	$-5.1M	↓ 28.26%
Financing Cash Flow	$3.4M	↓ 116.11%

Cai International Technicals Summary

Sell

Neutral

Buy

Cai International is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cai International Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cai International Inc	-17.72%	-45.33%	-36.82%	-33.5%	-61.72%
Regeneron Pharmaceuticals, Inc.	-0.55%	33.32%	9.7%	-2.63%	54.28%
Beone Medicines Ltd	-18.78%	-12.04%	12.07%	23.34%	-12.32%
Vertex Pharmaceuticals Incorporated	6.75%	24.8%	-2.1%	66.77%	124.17%
Alnylam Pharmaceuticals, Inc.	-1.57%	-31.91%	31.22%	69.55%	117.1%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cai International Inc	NA	NA	NA	0.15	-0.45	0.04	NA	2.04
Regeneron Pharmaceuticals, Inc.	18.62	18.69	1.66	44.79	0.15	0.06	0.0	304.65
Beone Medicines Ltd	123.64	120.53	NA	5.51	0.07	0.04	NA	39.34
Vertex Pharmaceuticals Incorporated	32.58	32.16	2.15	19.19	0.23	0.12	NA	73.49
Alnylam Pharmaceuticals, Inc.	136.94	136.94	-0.49	9.56	0.73	0.07	NA	5.96

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cai International Inc	NA	$5.3B	-61.72%	NA	-8.39%
Regeneron Pharmaceuticals, Inc.	Buy	$81.6B	54.28%	18.62	31.41%
Beone Medicines Ltd	NA	$35.3B	-12.32%	123.64	5.37%
Vertex Pharmaceuticals Incorporated	Buy	$126.8B	124.17%	32.58	32.94%
Alnylam Pharmaceuticals, Inc.	Buy	$42.5B	117.1%	136.94	8.45%

About Cai International Inc

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.

Organization	Cai International
Employees	1846
CEO	Dr. David Dean Halbert M.D.
Industry	Finance

Key Management of Cai International Inc

Name	Title
Dr. David Dean Halbert M.D.	Chairman, CEO & Founder
Mr. Brian J. Brille J.D.	Executive Vice Chairman & Executive VP
Dr. David Spetzler M.B.A., M.S., Ph.D.	President
Mr. Luke Power	Senior VP, CFO & Chief Accounting Officer
Mr. Jon Mark Harmon	Senior VP & Chief Operations Officer
Dr. Valeriy Domenyuk	Senior VP & CTO
Dr. Milan Radovich Ph.D.	Senior VP & Chief Scientific Officer
Ms. Ginger Appleberry J.D.	Senior VP, Deputy General Counsel & Chief Compliance Officer
Mr. J. Russel Denton	Senior VP, General Counsel & Secretary
Mr. Narendra Chokshi	Senior Vice President of Corporate Development

Important FAQs about investing in CAI Stock from India :

What is Cai International share price today?

Cai International share price today is $17.68 as on March 13, 2026 at 1:29 am IST at the close of the market. Cai International share today touched a day high of $18.26 and a low of $17.53.

What is the 52 week high and 52 week low for Cai International share?

Cai International share touched a 52 week high of $42.50 and a 52 week low of $17.15. Cai International stock price today i.e. March 13, 2026 at 1:29 am IST is closed at $17.68, lower by 58.4% versus the 52 week high.

How to invest in Cai International Stock (CAI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cai International on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cai International Shares that will get you 0.0848 shares as per Cai International share price of $17.68 per share as on March 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cai International Stock (CAI) from India?

Indian investors can start investing in Cai International (CAI) shares with as little as ₹92.1675 or $1 (as of March 13, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹921.68 in Cai International stock (as per the Rupee-Dollar exchange rate as on March 13, 2026). Based on Cai International share’s latest price of $17.68 as on March 13, 2026 at 1:29 am IST, you will get 0.5656 shares of Cai International. Learn more about fractional shares .

What are the returns that Cai International has given to Indian investors in the last 5 years?

Cai International stock has given -61.72% share price returns and 26.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?